GLI2 and colorectal cancer: Experimental studies have confirmed that phosphorylated c-Jun, activated by kinase JNK, prevents Gli2 from undergoing proteasomal-ubiquitin degradation through the PGE2-JNK signaling axis, thereby promoting Hh activation and colorectal cancer cell proliferation (68).